Catalyst Wire Dossier Catalyst Wire Dossier

AXOS (arabinoxylan-oligosaccharides)

arabinoxylan-oligosaccharides · Fugeia NV
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AXOS (arabinoxylan-oligosaccharides), covering 2009-10-27 to 2009-10-27. Get the full timeline:

Most recent: Clinical Trial Update: In Vivo Evaluation of the Physiological Effects of Arabinoxylan-oligosaccharides (AXOS) in Healthy Subjects (Juniors) [NA]

See pricing